Space.com15h
The force is strong with this JEDI
Step aside, Darth Vader. National Aeronautics and Space Administration (NASA)'s Joint Extreme ultraviolet lithography (EUV) ...
The Canadian Press on MSN1d
The Maple Leaf at 60: What the Canadian flag means to you
The Canadian flag, designed by George F. G. Stanley, is celebrating its 60th anniversary on Feb. 15. We asked Canadians across the country for their thoughts on what the Maple Leaf means to them at ...
Lisa Rinna explains why sex is ‘different’ and ‘better’ after 60
The “Real Housewives of Beverly Hills” alum previously told Cosmopolitan readers about her and husband Harry Hamlin’s “great ...
Could This Cathie Wood EV Stock Be the Next Tesla?
Tesla's overall business has more dimensions to it than that of Archer. Beyond EVs, it also produces energy storage packs and is current investing heavily in artificial intelligence (AI) -- primarily ...
Use Your Lawn Mower Year-Round With This Handy Attachment
The best lawn mower snow blower combos can go from cutting grass to moving snow in no time, making them useful year-round tools. See our list of top picks.
Impacts10d
Skyhawk Drone Reviews 2025: (Customer Complaints A Hoax?) Read Shocking User Report!
Are you searching for affordable and functional drone for your professional and personal use? If yes then you are on the ...
Plane at 90-degree angle seconds before it hit the ground
A military helicopter collided with an American Airlines flight over the US capital of Washington, DC. There are not believed to be any survivors. ...
Yahoo Finance16d
60 Degrees Pharma Announces Closing of $1.043 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
WASHINGTON, Jan. 30, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for ...
BioSpace18d
60 Degrees Pharma Announces $1.043 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
WASHINGTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious ...
Nasdaq18d
60 Degrees Pharmaceuticals, Inc. Receives IRB Approval for Phase II Clinical Study of Tafenoquine in Chronic Babesiosis Treatment
60 Degrees Pharmaceuticals, Inc. announced the approval of an Investigational Review Board (IRB) for a Phase II clinical study aimed at evaluating the efficacy and safety of tafenoquine ...
Business Insider18d
60 Degrees announces IRB approval of Phase II study of Tafenoquine
60 Degrees Pharmaceuticals (SXTP) announced the approval of an Investigational Review Board, IRB, sanctioned Phase II clinical study. The study will evaluate the efficacy and safety of the ARAKODA ...
BioSpace19d
60 Degrees Pharma Announces IRB Approval of Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis
Enrollment expected to commence Q3 2025. WASHINGTON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on ...